Meeting
2012 ASCO Annual Meeting
Central nervous system involvement in T-cell lymphomas: A single center experience.
Authors
Ronit Gurion
Rabin Medical Center, Petach Tikva, Israel
Ronit Gurion , Jocelyn Maragulia , Andrew David Zelenetz , Steven M. Horwitz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 30, 2012 (suppl; abstr 8069)
DOI
10.1200/jco.2012.30.15_suppl.8069
Abstract #
8069
Poster Bd #
35B
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
CNS relapse in DLBCL patients below 60 years treated with R-ACVBP, R-CHOEP, or R-CHOP: A joint analysis of LYSA and GLA/DSHNHL.
First Author: Catherine Thieblemont
Poster
2017 ASCO Annual Meeting
Patterns of use of CNS prophylaxis in DLBCL in a large health system.
First Author: Michael A. Thompson
Poster
2014 ASCO Annual Meeting
U.S. Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881).
First Author: Paul M. Barr
Poster
2021 ASCO Quality Care Symposium
Can high-dose methotrexate be safely administered to outpatients?
First Author: Briana Genge